Literature DB >> 8766043

[Circulatory disorders of the choroid in patients with central serious chorioretinopathy].

C Prünte1, J Flammer.   

Abstract

BACKGROUND: Advanced methods for indocyanine green (ICG) video-fluorescence angiography provide improved evaluation of choroidal blood flow disturbances in patients with central serous chorioretinopathy (CSC). MATERIAL AND
METHOD: Fluorescein ICG video-fluorescence angiography using a laser scanning ophthalmoscope and digital image processing were performed in patients with acute or chronic recurrent CSC.
RESULTS: In all eyes examined delayed arterial filling followed by capillary and/or venous congestion were found in the areas of retinal pigmentepithelial detachment or leakage. Furthermore, additional ischemic choroidal capillary lobuli could be observed throughout the fundus of diseased eyes and "normal" fellow eyes.
CONCLUSIONS: Our results suggest that symptomatic changes in CSC, like RPEdetachment or leakage from the outer blood-retinal barrier, may be caused by capillary and venous congestion, possibly due to stress-related arterial hypoperfusion.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8766043     DOI: 10.1055/s-2008-1035231

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  3 in total

1.  Obstructive sleep apnea in patients with central serous chorioretinopathy.

Authors:  Patrik Kloos; Irene Laube; Adelheid Thoelen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-11       Impact factor: 3.117

2.  Neutrophil/lymphocyte ratio and mean platelet volume in central serous chorioretinopathy.

Authors:  Muhammet Kazim Erol; Ayse Balkarli; Ozgur Yucel; Yusuf Akar; Berna Dogan; Elcin Suren
Journal:  Ther Clin Risk Manag       Date:  2017-07-28       Impact factor: 2.423

Review 3.  The discovery of the Flammer syndrome: a historical and personal perspective.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2017-05-22       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.